Ford, Kevin R.
Taylor, Jeffrey B.
Westbrook, Audrey E.
Paterno, Mark V.
Huang, Bin
Nguyen, Anh-Dung
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (R21AR069873)
National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (R21AR069873)
National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (R21AR069873)
National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (R21AR069873)
National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (R21AR069873)
National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (R21AR069873)
Article History
Received: 24 April 2024
Accepted: 10 April 2025
First Online: 15 April 2025
Declarations
:
: Participants were fully informed of the risks and benefits associated with this study and provided written participant informed consent, and/or parental informed consent and participant assent as appropriate. The study protocol was approved by the Institutional Review Board at High Point University and registered as a clinical trial (Clinicaltrials.gov Identifier: NCT02754700, Date Registered 28/04/2016).
: Not applicable.
: The authors declare no competing interests.